FMA
RMD icon

FNY Managed Accounts’s ResMed RMD Stock Holding History

FNY Managed Accounts’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,000
Closed -$235K – 170
2013
Q4 		$235K Sell
5,000
-14,260
-74% -$722K 0.36% 54
2013
Q3 		$1.02M Buy
+19,260
New +$934K 1.13% 14

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

FNY Managed Accounts's RMD Position: Q1 2014 in Review

FNY Managed Accounts sold out of ResMed (RMD) in Q1 2014, closing a stake of 5,000 shares — an estimated $235K sold.

FNY Managed Accounts first reported a position in RMD in Q3 2013 and held it in 2 quarters. The position peaked at $1.02M in Q3 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

  • FNY Managed Accounts reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
  • FNY Managed Accounts sold 5,000 ResMed shares in Q1 2014, an estimated $235K.
  • FNY Managed Accounts first reported a position in ResMed in Q3 2013 and held it in 2 quarters.
  • FNY Managed Accounts's ResMed position peaked at $1.02M in Q3 2013.
  • 318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on FNY Managed Accounts's 13F filing for Q1 2014, filed 15 May 2014.